Multiple antibody status in type I diabetic patients and subjects at various risk with islet-cell antibodies;Multiplicite d'anticorps chez des diabetiques de type 1 et chez des sujets ICA-positifs a risques variables

Diabetes and Metabolism

Volumn 23, Issue 4, 1997, Pages 320-327

  Maugendre, D ^a,h   Chaillous, L ^b,f   Rohmer, V ^c   Lecomte, P ^d   Marechaud, R ^e   Sai P ^b,f   Marre, M ^c   Charbonnel, B ^b,f   Allannic, H ^a   Delamaire, M ^g  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c Ctr Hosp Universitaire de Angers   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e POITIERS UNIVERSITY HOSPITAL   (France)

^f Laboratoire d'Immunoendocrinologie   (France)

^g Etablissement de Transfus Sanguine   (France)

^h SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Autoantibodies; Diabetes prediction; Insulin dependent (Type 1) diabetes mellitus; Protein tyrosine phosphatase

Indexed keywords

AUTOANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FAMILY HISTORY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; RISK FACTOR;

ANIMALS; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; ISLETS OF LANGERHANS; MALE; MICE; MOLECULAR STRUCTURE; RATS; RATS, WISTAR; RISK FACTORS;

EID: 9844226788     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Eisenbarth GS. Type 1 diabetes mellitus : a chronic autoimmune disease. N Engl J Med. 1986, 314, 1360-1368.
2. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Rev, 1994, 15, 516-542.
3. Chaillous L. Delamaire M, Elmansour A, et al. Combined analysis of islet cell antibodies which crossreact with mouse pancreas, antibodies to the 64.000 islet protein, and antibodies to glutamate decarboxylase, in subjects at risk for IDDM. Diabetologia. 1994, 37, 491-499.
4. Chaillous L, Delamaire M, Martignat L, et al. Combined analysis of islet cell antibodies which crossreact with mouse pancreas, antibodies to the 64.000 islet protein, and antibodies to glutamate decarboxylase, in type 1 diabetic patients. Diabetes Care. 1994, 17, 1115-1123.
5. Baekkeskov S, Aanstoot HJ, Christgau S, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990, 347, 151-156.
6. Palmer JP, Asplin CM, Clemons P et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science, 1983, 222, 1337-1339.
7. Thivolet CH, Tappaz M, Durand A, et al. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type I (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia. 1992, 15, 570-576.
8. Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL. Distinct antibody specificities to a 64-kD islet cell antigen in type I diabetes as revealed by trypsin treatment. J Exp Med, 1990, 172, 789-794.
9. Bingley PJ, Christie MR, Bonifacio E, et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes, 1994, 43, 1304-1310.
10. Genovese S, Bingley PJ, Bonifacio E, et al. Combined analysis of IDDM-related autoantibodies in healthy schoolchildren. Lancet, 1994, 344, 756.
11. Christie MR, Genovese S, Cassidy D, et al. Antibodies to islet 37 k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in healthy endocrine autoimmunity. Diabetes, 1994, 43, 1254-1259.
12. Payton MA, Hawkes J, Christie M.R. Relationship of the 37.000 - and 40.000 - Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest. 1995, 96, 1506-1511.
13. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E. Identification of the protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40k autoantigen and a target of islet-cell antibodies. J Immunol. 1995, 155, 5419-5426.
14. Passini N, Larigan JD, Genovese S, Appella E, Sinigaglia F, Rogge L. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc Natl Acad Sci. USA. 1995, 92, 9412-9416.
15. Lu J, Xie H, Chen ZJ, et al. Identification of a second transmembrane protein tyrosine phosphatase IA-2β, as an autoantigen in insulin-dependent diabetes mellitus : precursor of the 37-kDa tryptic fragment. Proc. Natl. Acad. Sci. USA. 1996, 93, 2307-2311.
16. Hawkes CJ, Wasmeier C, Christie MR, Hutton JC. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes. 1996, 45, 1187-1192.
17. Levy-Marchal C, Tichet J, Fajardy I, Gu XF, Dubois F, Czernichow P. Islet cell antibodies in normal French schoolchildren. Diabetologia, 1992; 35, 577-82.
18. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974, 2, 1279-1283.
19. Pilcher C, Elliott RB. Improved sensitivity of islet cell cytoplasmic antibody assay in diabeties. Lancet. 1984, 1, 1352.
20. Bonifacio E, Lernmark A, Dawkins RL. Serum exchange and the use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods. 1988, 106, 83-88.
21. Sai P, Elmansour A, Audrain M, Charbonnel B, Bardet S. Quantification of human cytoplasmic islet-cell antibodies which cross-react with mouse pancreas : a follow-up in type 1 diabetic patients and in first-degree relatives. Diabetologia. 1993, 36, 778-784.
22. Christie MR, Tun RYM, Lo SSS, et al. Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM. Studies with identical twins. Diabetes. 1992, 41, 782-787.
23. Delamaire M, Timsit J, Caillat-Zuckman S, et al. HLA control of anti-islet cell humoral response heterogeneity in patients with type I diabetes. J Autoimmunity, 1995, 8, 645-657.
24. Bonifacio E, Genovese S, Braghi S, et al. Islet autoantibody markers in IDDM : risk assessment strategies yielding high sensitivity. Diabetologia. 1995, 38, 816-822.
25. Oncagna JC, Levy-Marchal C. 37 kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies. Diabetologia. 1995, 38, 370-375.
26. Rabin DU, Pleasic Sm, Shapiro JA, et al. Islet cell antigen 512 is a diabetes-specific islet antigen related to protein tyrosine phosphatases. J Immunol. 1994, 152, 3183-3188.
27. Gorus FK, Goubert P, Semakula C, et al. IA-2-autoantibodies complement GAD 65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia, 1997, 40, 95-99.
28. Myers MA, Rabin DU, Rowley MJ, Pancreatic islet cell antibody in diabetes is represented by antibodies to islet cell antisen 512 and glutamic acid decarboxylase. Diabetes, 1995, 44, 1290-1295.
29. Lan MS, Wasserfall C, Maclaren NK, Notkins AL. IA-2, a trans-membrane protein of the protein tyrosine phosphatase family is a major antigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA, 1996, 93, 6367-6370.
30. Verge CF, Gianani R, Kawasaki E, et al. Prediction of type 1 diabetes in first degree relatives using a combination of insulin. GAD and ICA512bdc/IA2 autoantibodies. Diabetes. 1996, 45, 926-933.
31. Verge CF, Gianani R, Kawasaki E, Pietropaolo M, Chase HP, Eisenbarth G. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type 1 diabetes. J Autoimmunity, 1996, 9, 379-383
32. Wiest-Ladenburger U, Harmann R, Harmann U, Berling K, Böhm BO, Richter W. Combined analyis and single step detection of GAD 65 and IA2 autoantibodies can replace the histochemical islet cell antibody test. Diabetes. 1997, 46, 565-571.
33. Kawasaki E, Yu L, Gianini R, et al. Evaluation of islet cell antigen (ICA) 512/IA2 autoantibody radioassays using overlapping ICA 512/IA2 constructs. J Clin Endoc Metab. 1997, 82, 375-380.
34. Kawasaki E, Abiru N, Yano M, et al. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease : relation to competitive insulin autoantibodies. J Autoimmunity, 1995, 8, 633-643.
35. Hallengren B, Falorni A, Landin-Olsson M, Lernmark A, Papadopoulos KI, Sundkvist G. Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients : at diagnosis and following treatment. J Int Med. 1996, 239, 63-68.